Pharmaceutical Technologist - January 2008 - (Page 29) Q&A next 5 years. We appreciate the input many of you provided during the consultation, which will be valuable in arriving at our final strategy soon to be published. As well as operating the current regulatory system, the MHRA works to influence the shape of future regulation. The MHRA is particularly active in taking a lead in developing new approaches in Europe, as well as internationally. As new technologies, such as tissue engineering start to offer new treatment possibilities, the MHRA is helping to design and implement new safeguards, usually through new EU legislation. The MHRA recognizes that safeguarding public health is dependent on an effective partnership with our key stakeholders including Industry. Our Better Regulation of Medicines Initiative and the introduction of risk-based inspections are evidence of our commitment to find new ways of developing our relationship with Industry for the benefit of UK citizens. PT Gerald Heddell www.mhra.gov.uk www.ptemagazine.com 29 http://www.mhra.gov.uk http://www.ptemag.com/subscribe http://www.ptemag.com/subscribe http://www.ptemagazine.com
Table of Contents Feed for the Digital Edition of Pharmaceutical Technologist - January 2008 Pharmaceutical Technologist - January 2008 Contents Editor's Comment News Morpheus Market Watch Lagging Japanese Drug R&D Croatia’s Innovation Integrating PAT with Biopharmaceutical Development and Manufacture Q&A Pharmaceutical Technologist - January 2008 Pharmaceutical Technologist - January 2008 - Pharmaceutical Technologist - January 2008 (Page 1) Pharmaceutical Technologist - January 2008 - Pharmaceutical Technologist - January 2008 (Page 2) Pharmaceutical Technologist - January 2008 - Contents (Page 3) Pharmaceutical Technologist - January 2008 - Contents (Page 4) Pharmaceutical Technologist - January 2008 - Editor's Comment (Page 5) Pharmaceutical Technologist - January 2008 - News (Page 6) Pharmaceutical Technologist - January 2008 - News (Page 7) Pharmaceutical Technologist - January 2008 - News (Page 8) Pharmaceutical Technologist - January 2008 - News (Page 9) Pharmaceutical Technologist - January 2008 - Morpheus (Page 10) Pharmaceutical Technologist - January 2008 - Morpheus (Page 11) Pharmaceutical Technologist - January 2008 - Market Watch (Page 12) Pharmaceutical Technologist - January 2008 - Market Watch (Page 13) Pharmaceutical Technologist - January 2008 - Lagging Japanese Drug R&D (Page 14) Pharmaceutical Technologist - January 2008 - Lagging Japanese Drug R&D (Page 15) Pharmaceutical Technologist - January 2008 - Lagging Japanese Drug R&D (Page 16) Pharmaceutical Technologist - January 2008 - Lagging Japanese Drug R&D (Page 17) Pharmaceutical Technologist - January 2008 - Croatia’s Innovation (Page 18) Pharmaceutical Technologist - January 2008 - Croatia’s Innovation (Page 19) Pharmaceutical Technologist - January 2008 - Croatia’s Innovation (Page 20) Pharmaceutical Technologist - January 2008 - Croatia’s Innovation (Page 21) Pharmaceutical Technologist - January 2008 - Croatia’s Innovation (Page 22) Pharmaceutical Technologist - January 2008 - Integrating PAT with Biopharmaceutical Development and Manufacture (Page 23) Pharmaceutical Technologist - January 2008 - Integrating PAT with Biopharmaceutical Development and Manufacture (Page 24) Pharmaceutical Technologist - January 2008 - Integrating PAT with Biopharmaceutical Development and Manufacture (Page 25) Pharmaceutical Technologist - January 2008 - Integrating PAT with Biopharmaceutical Development and Manufacture (Page 26) Pharmaceutical Technologist - January 2008 - Q&A (Page 27) Pharmaceutical Technologist - January 2008 - Q&A (Page 28) Pharmaceutical Technologist - January 2008 - Q&A (Page 29)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.